Aridis Pharmaceuticals, Inc. - Common Stock (ARDS)

CUSIP: 040334104

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
44,586,623
Total 13F shares
1,269,305
Share change
-722,789
Total reported value
$2,956,583
Price per share
$2.33
Number of holders
18
Value change
-$3,467,952
Number of buys
11
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 040334104?
CUSIP 040334104 identifies ARDS - Aridis Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q4 2021

As of 31 Dec 2021, Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,269,305 shares. The largest 10 holders included VANGUARD GROUP INC, Roumell Asset Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., JANE STREET GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, PERRITT CAPITAL MANAGEMENT INC, COMMONWEALTH EQUITY SERVICES, LLC, and NORTHERN TRUST CORP. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.